Tech Center 1600 • Art Units: 1632
This examiner grants 11% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17600377 | Gene Therapy For Eye Pathologies | Final Rejection | REGENXBIO Inc. |
| 17611007 | NEURAL CELL POPULATION, NEURAL CELL-CONTAINING PREPARATION, AND METHOD FOR PRODUCING SAID POPULATION AND PREPARATION | Final Rejection | UNIVERSITY OF TSUKUBA |
| 16969523 | Cell Mass Fusion Method | Final Rejection | Public University Corporation Yokohama City University |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy